Targets of histone deacetylase inhibitors in ovarian cancer identified using proteome integral solubility alteration

ABSTRACT: Using proteome integral solubility alteration (PISA) to assess HDAC inhibitor targets across ovarian cancer and acute lymphoblastic leukemia cell types

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Suspension Culture, Epithelial Cell, Cell Culture

DISEASE(S): Acute Leukemia,Malignant Neoplasm Of Ovary

SUBMITTER: Jolene Duda  

LAB HEAD: Stefani Thomas

PROVIDER: PXD055375 | Pride | 2024-12-19

REPOSITORIES: Pride